Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Accuitis
AddedFeb 16, 2024
UpdatedJun 18, 2026
Accuitis

Accuitis

Pre-Seed

Accuitis, a Georgia-based pharmaceutical company, specializes in developing treatments for niche and underserved diseases.

HQ
Alpharetta, GA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Accuitis, a pharmaceutical company based in Cumming, Georgia, was founded in 2011. The company is dedicated to the development of first-in-class disease-modifying therapeutics for niche, orphan, and underserved disease states. Accuitis focuses on acquiring and developing pharmaceuticals that address significant unmet medical needs, aiming to improve patient outcomes in areas often overlooked by larger pharmaceutical companies.

Accuitis has made notable strides in its mission to bring innovative treatments to market, particularly for diseases that lack sufficient therapeutic options. The company's commitment to addressing underserved medical conditions has positioned it as a key player in the niche pharmaceutical sector, contributing to advancements in healthcare for patients with rare and neglected diseases.

Accuitis - Similar Companies

Assertio Holdings logo

Assertio Holdings

Iacta Pharmaceuticals logo

Iacta Pharmaceuticals

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

PleoPharma logo

PleoPharma

pleopharma.com

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Accera logo

Accera

Aquavit Pharmaceuticals logo

Aquavit Pharmaceuticals

aquavitpharma.com

Argentis Pharmaceuticals logo

Argentis Pharmaceuticals

argentisrx.com

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Aquestive Therapeutics logo

Aquestive Therapeutics

aquestive.com

Intellimedix logo

Intellimedix

Essential Remedium logo

Essential Remedium

Chiesi USA logo

Chiesi USA

chiesi.com

Aptinyx logo

Aptinyx

aptinyx.com

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Accuitis - Quick Facts

Who are Accuitis' competitors?

Companies similar to Accuitis include Assertio Holdings, Iacta Pharmaceuticals, Manhattan Pharmaceuticals and PleoPharma.

When was Accuitis founded?

Accuitis was founded in 2011.

Where is Accuitis' headquarters located?

Accuitis' headquarters is located in Alpharetta, GA, US.

When was Accuitis' last funding round?

Accuitis' most recent funding round was for $1M (USD) in August 2018.

How much has Accuitis raised to-date?

As of Aug 31, 2018, Accuitis has raised a total of $3.8M (USD).

How many employees does Accuitis have?

Accuitis has 2 employees as of Feb 5, 2024.

Accuitis - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified